Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X ETF

129.79
+3.943.13%
Pre-market: 129.70-0.0900-0.07%04:27 EDT
Volume:51.06K
Turnover:6.65M
Market Cap:162.24M
PE:- -
High:133.00
Open:126.73
Low:126.72
Close:125.85
52wk High:150.00
52wk Low:82.41
Shares:1.25M
Float Shares:1.25M
Volume Ratio:1.07
T/O Rate:4.08%
Dividend:1.26
Dividend Rate:0.97%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

Benzinga Earnings
·
1 hour ago

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
12 hours ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement

TradingKey
·
16 hours ago

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
16 hours ago

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
17 hours ago

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Reuters
·
Yesterday

Eli Lilly is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Yesterday

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.
·
Yesterday

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Yesterday

AlzeCure Pharma to Present at Redeye Neurology Day

Reuters
·
Yesterday

Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital

TIPRANKS
·
Yesterday

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

TIPRANKS
·
Yesterday

General Medicine Raises $120 Mln to Build the Healthcare Store

Reuters
·
Oct 06

General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company

THOMSON REUTERS
·
Oct 06

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
Oct 06

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Dow Jones
·
Oct 05

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Oct 05

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Oct 05

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Oct 05

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Oct 05